Senior insider sale
Chief Business Officer at ARBUTUS BIOPHARMA CORP — senior position signals high conviction
$974.9K
300K shares
What this filing means
MCELHAUGH MICHAEL J. plans to sell 300K shares of ARBUTUS BIOPHARMA CORP valued at approximately $974.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/21/2025ACC: 0001965301-25-000046
Officer· Chief Business Officer
Since Dec 2018
300K
Shares to sell
$974.9K
Approx. market value
246.89K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Award
Compensation
9/26/2015
246.89KTotal acquired246.89K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/26/2015 | Stock Award Compensation | 246.89K | — |
| Total | 246.89K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
53.11K
Market value
$170.1K
4/15/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
246.89K
Market value
$804.9K
4/21/2025
Total
Units
300K
Value
$974.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/15/2025 | 53.11K | $170.1K | — | Completed |
| Planned — Approximate Date | ||||
4/21/2025 | 246.89K | $804.9K | NASDAQ | Planned |
| Total | 300K | $974.9K | ||